End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
13.14
CNY
|
-2.95%
|
|
-3.17%
|
-7.72%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,916
|
4,071
|
3,308
|
3,052
|
-
|
Enterprise Value (EV)
1 |
3,916
|
4,071
|
3,308
|
3,052
|
3,052
|
P/E ratio
|
44.7
x
|
31.3
x
|
21.3
x
|
16.4
x
|
13.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
5.78
x
|
3.94
x
|
3.16
x
|
2.72
x
|
EV / Revenue
|
-
|
5.78
x
|
3.94
x
|
3.16
x
|
2.72
x
|
EV / EBITDA
|
-
|
23.6
x
|
14.7
x
|
11
x
|
9.11
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
5.69
x
|
4.02
x
|
3.19
x
|
2.7
x
|
Nbr of stocks (in thousands)
|
232,471
|
232,387
|
232,324
|
232,304
|
-
|
Reference price
2 |
16.85
|
17.52
|
14.24
|
13.14
|
13.14
|
Announcement Date
|
4/22/22
|
4/7/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
704.5
|
839.3
|
967
|
1,122
|
EBITDA
1 |
-
|
172.5
|
224.5
|
277
|
335
|
EBIT
1 |
-
|
136.3
|
185.4
|
213
|
253
|
Operating Margin
|
-
|
19.34%
|
22.1%
|
22.03%
|
22.55%
|
Earnings before Tax (EBT)
1 |
-
|
136.4
|
185.8
|
213
|
253
|
Net income
1 |
89.25
|
130.7
|
161.5
|
187
|
222
|
Net margin
|
-
|
18.55%
|
19.25%
|
19.34%
|
19.79%
|
EPS
2 |
0.3769
|
0.5600
|
0.6700
|
0.8000
|
0.9500
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/22/22
|
4/7/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
19.4%
|
20.5%
|
19.3%
|
19.5%
|
ROA (Net income/ Total Assets)
|
-
|
12.2%
|
-
|
10.5%
|
11%
|
Assets
1 |
-
|
1,072
|
-
|
1,781
|
2,018
|
Book Value Per Share
2 |
-
|
3.080
|
3.540
|
4.120
|
4.870
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
66.6
|
54.8
|
198
|
188
|
Capex / Sales
|
-
|
9.46%
|
6.53%
|
20.48%
|
16.76%
|
Announcement Date
|
4/22/22
|
4/7/23
|
4/25/24
|
-
|
-
|
Last Close Price
13.14
CNY Average target price
18
CNY Spread / Average Target +36.99% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.72% | 423M | | +31.37% | 595B | | -2.60% | 367B | | +20.83% | 334B | | +5.69% | 289B | | +14.83% | 239B | | +9.93% | 211B | | -6.95% | 203B | | +10.77% | 171B | | +0.10% | 163B |
Other Pharmaceuticals
|